OptiBio
Optical Q
Fluorescence
Immunoassay
Diagnostic Device
in-vitro diagnostics fluorescence
immunoassay analyzer
The Optical Q™, developed by Optibio, is a cutting edge in-vitro diagnostics (IVD) fluorescence immunoassay (FIA) analyzer designed for Point-of-Care use. It delivers quantitative results in just 3-15 minutes from samples like blood, plasma, or urine, covering over 20 test parameters spanning inflammation, infection, hormones, thyroid, cardiac markers and more. With built-in RFID, internal printer, compact footprint, and CE-IVD certification, it offers healthcare professionals an accessible, reliable solution for rapid diagnostics.
Fast Quantitative Results
Provides test results in just 3-15 minutes, enabling physicians and clinics to make quick diagnostic decisions.
Multiple Test Parameters
Supports a wide range of assays including infection markers, hormones, inflammation indicators, thyroid markers, cardiac markers, etc.
.png)
Point-of-Care (POCT) Friendly
Portable and user-friendly: compact design, minimal setup; ideal for clinics, specialists, and decentralized testing.
Advanced Technology & Certification
Utilises Fluorescence Immunoassay (FIA) methodology with built-in features like RFID and an internal printer; designed to meet international regulatory standards.
Thyroid
Tests for TSH, T3, and T4 hormones, supporting accurate diagnosis and monitoring of thyroid function. These assays help clinicians detect hyperthyroidism, hypothyroidism, and monitor therapy effectiveness.
Cardiovascular Disease
A comprehensive panel including CK-MB, D-Dimer, Myoglobin, NT-proBNP, Troponin I, and AHT for cardiac risk and event assessment. This helps detect acute cardiac events, heart failure, and thrombotic disorders quickly and effectively.
Diabetes
HbA1c testing provides reliable long-term monitoring of blood glucose control. It offers an accurate picture of a patient’s average blood sugar levels over the past 2–3 months.
Inflammation
CRP and PCT markers help identify infections and guide treatment decisions. They are especially useful in distinguishing bacterial from viral infections and tracking disease progression.
Tumor
AFP, CEA, and PSA markers support early detection and follow-up of certain cancers. These tests assist doctors in screening, monitoring treatment response, and tracking recurrence.
Hormone
Tests for beta-hCG, cortisol, FSH, ALH, progesterone, prolactin, and testosterone to evaluate endocrine and reproductive health. These markers are key in fertility testing, pregnancy monitoring, and hormone imbalance diagnosis.
Other
Vitamin D and ferritin testing to monitor nutrition, metabolism, and iron storage levels. These markers play an important role in detecting deficiencies that can impact immunity, bone health, and overall wellbeing.